📰 7 sources covering this story

AstraZeneca halts lung cancer trial in latest blow to pipeline

First covered 2 hrs ago · latest take 28 mins ago. Compare how each outlet is covering it — and rate the sources you trust.

The Times28 mins ago

AstraZeneca halts lung cancer trial in latest blow to pipeline The Times

The FTSE 100 firm stopped a stage volrustomig drug trial a month after halting a trial for a new heart disease treatment.

The FTSE 100 firm stopped a stage volrustomig drug trial a month after halting a trial for a new heart disease treatment.

The FTSE 100 firm stopped a stage volrustomig drug trial a month after halting a trial for a new heart disease treatment.

AstraZeneca Ends Phase Three Lung Cancer Drug Trial After Review WSJ

Reuters🏁 first to report2 hrs ago

AstraZeneca to discontinue late-stage lung cancer trial for volrustomig Reuters